Loading...
XHKG
0239
Market cap98mUSD
Jul 16, Last price  
2.49HKD
1D
0.00%
1Q
9.21%
Jan 2017
-30.25%
Name

Pak Fah Yeow International Ltd

Chart & Performance

D1W1MN
P/E
9.87
P/S
3.27
EPS
0.25
Div Yield, %
4.50%
Shrs. gr., 5y
—
Rev. gr., 5y
9.95%
Revenues
237m
-8.44%
96,208,000100,090,000101,456,000114,449,000107,959,000107,889,000115,931,000128,543,000162,016,000187,453,000182,570,000183,159,000179,981,000141,665,000147,761,000109,343,000139,823,000147,200,000259,312,000237,430,000
Net income
79m
-25.14%
33,635,00042,097,00036,006,000-18,189,00059,567,00055,013,00046,228,00064,344,00070,880,000146,465,00061,014,00061,199,000102,589,00037,280,00036,046,000-38,356,00038,186,00029,955,000105,039,00078,629,000
CFO
0k
-100.00%
24,516,00028,096,00023,410,00038,803,00033,479,00034,819,00023,304,00070,872,00055,703,00041,144,00072,351,00065,421,00098,816,00055,658,00048,748,0008,260,00070,358,00039,920,000147,899,0000
Dividend
Jul 07, 20250.105 HKD/sh
Earnings
Aug 25, 2025

Profile

Pak Fah Yeow International Limited, together with its subsidiaries, manufactures, markets, and distributes healthcare products under the Hoe Hin brand name in the People's Republic of China, Hong Kong, Macau, Southeast Asia, North America, the United Kingdom, and internationally. It operates through three segments: Healthcare, Property Investments, and Treasury Investments. The company offers white flower embrocation medicated oils, strain relief products, and ointments under, as well as Fúzai 239, a floral-scented white flower embrocation. In addition, it invests in commercial, industrial, residential, and car park properties; and provides advertising agency services. The company was founded in 1927 and is headquartered in Wan Chai, Hong Kong.
URL
https://www.pakfahyeow.com/
IPO date
Dec 18, 1991
Employees
99
Domiciled in
HK
Incorporated in
BM

Valuation

Title
HKD in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2024‑122023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑122015‑12
Income
Revenues
237,430
-8.44%
259,312
76.16%
147,200
5.28%
Cost of revenue
91,141
108,686
93,103
Unusual Expense (Income)
NOPBT
146,289
150,626
54,097
NOPBT Margin
61.61%
58.09%
36.75%
Operating Taxes
19,134
23,767
7,815
Tax Rate
13.08%
15.78%
14.45%
NOPAT
127,155
126,859
46,282
Net income
78,629
-25.14%
105,039
250.66%
29,955
-21.56%
Dividends
(47,629)
(24,585)
Dividend yield
8.63%
6.36%
Proceeds from repurchase of equity
BB yield
Debt
Debt current
4,204
4,737
5,496
Long-term debt
2,073
Deferred revenue
39,050
36,773
Other long-term liabilities
90,559
8,032
5,350
Net debt
(295,181)
(265,674)
(442,668)
Cash flow
Cash from operating activities
147,899
39,920
CAPEX
(3,061)
(156)
Cash from investing activities
16,652
(156)
Cash from financing activities
(48,963)
(33,906)
FCF
(53,477)
149,943
43,404
Balance
Cash
294,518
277,607
180,340
Long term investments
4,867
(7,196)
269,897
Excess cash
287,514
257,445
442,877
Stockholders' equity
15,582
743,186
685,228
Invested Capital
811,089
559,557
313,113
ROIC
18.55%
29.07%
14.97%
ROCE
17.70%
17.35%
6.70%
EV
Common stock shares outstanding
311,640
311,640
311,640
Price
2.48
40.11%
1.77
42.74%
1.24
-21.52%
Market cap
772,867
40.11%
551,603
42.74%
386,434
-21.52%
EV
477,686
285,929
(56,234)
EBITDA
146,289
158,014
61,581
EV/EBITDA
3.27
1.81
Interest
615
644
Interest/NOPBT
0.41%
1.19%